Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging

What Was Tested

Researchers studied Parathyroid Hormone (PTH 1-84) in this clinical trial publication.

Intraoperative parathyroid hormone assay (IOPTH) is often used during minimally invasive parathyroidectomy (MIP) for primary hyperparathyroidism (pHPT).

However, several investigators have reported conflicting outcomes, throwing doubt on the real influence of this adjunct on surgical decision-making.

The aim of this study was to determine the impact of routine use of IOPTH on the success rate of MIP as the primary outcome, and whether it value-added to surgical decision-making during the operations at their institution.

Who Took Part

The abstract describes 177 patients taking part.

The age groups tagged for this paper are adults, middle-aged adults, older adults and people over 80, both men and women.

The results of MIP were determined on postoperative follow-up in 177 consecutive patients with pHPT and compared with the results of preoperative imaging, findings at surgery and the value-added accuracy of IOPTH in surgical decisions.

All 177 patients had biochemically documented pHPT and all were referred for first-time surgery.

How the Study Was Run

Group 1 patients (n = 62) underwent a unilateral neck exploration (UNE) without IOPTH, and group 2 patients (n = 115) underwent MIP (either video-assisted or open) with IOPTH.

What Was Measured

Topics PubMed links to this paper include Adenoma, Case-Control Studies, Chi-Square Distribution, Hyperparathyroidism, Monitoring, Intraoperative, Parathyroid Hormone and Parathyroid Neoplasms.

What This Means in Plain Language

This is a clinical trial of Parathyroid Hormone (PTH 1-84) in 177 patients.

Results are reported in around 12 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2007 (Clinical endocrinology), a journal based in England.

More context: the Parathyroid Hormone (PTH 1-84) compound page, all human trials.